The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government, has awarded a $26,525.00 firm fixed-price purchase order contract to Miltenyi Biotec, Inc. for annual maintenance of the MACS Quant Tyto Cell Sorter. This contract, which runs from March 14, 2025 to March 13, 2026, does not have a set-aside designation.
Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. The company has extensive experience as a prime contractor for numerous federal agencies, including the NIH, VA, FDA, DoD, CDC, and USDA. This contract award represents an ongoing relationship between Miltenyi Biotec and NIAID, which has previously leveraged the company's cell separation, analysis, and processing technologies to support its biomedical research programs, particularly in areas such as cancer, immunology, and infectious diseases.
Generated 3/13/25, 9:43 AM